Gregory E Idos
Overview
Explore the profile of Gregory E Idos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
920
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Naghi L, Culver J, Ricker C, Sturgeon D, Kingham K, Hodan R, et al.
JAMA Netw Open
. 2025 Jan;
8(1):e2454447.
PMID: 39804645
Importance: Enhanced breast cancer screening with magnetic resonance imaging (MRI) is recommended to women with elevated risk of breast cancer, yet uptake of screening remains unclear after genetic testing. Objective:...
2.
Lee R, Singh D, Idos G
Cureus
. 2024 Nov;
16(10):e70990.
PMID: 39507199
Esophageal impingement due to hardware failure is a rare complication of cervical spine fusion surgery; dysphagia, on the other hand, is a much more common complication. Here, we present the...
3.
McDonnell K, Rennert G, Idos G
Front Oncol
. 2024 Oct;
14:1474157.
PMID: 39450251
No abstract available.
4.
Tsai Y, Nair K, Barot S, Xiang S, Kamath S, Melas M, et al.
J Natl Cancer Inst
. 2024 Jun;
116(10):1645-1653.
PMID: 38902947
The incidence of colorectal cancer (CRC) among individuals younger than age 50 (early-onset CRC [EOCRC]) has substantially increased, and yet the etiology and molecular mechanisms underlying this alarming rise remain...
5.
Hodan R, Picus M, Stanclift C, Ormond K, Pichardo J, Kurian A, et al.
J Community Genet
. 2024 May;
15(4):363-374.
PMID: 38814439
Previous research on family communication of cancer genetic test results has primarily focused on non-Hispanic White patients with high-risk pathogenic variants (PV). There are limited data on patient communication of...
6.
Chen Z, Guo X, Tao R, Huyghe J, Law P, Fernandez-Rozadilla C, et al.
Nat Commun
. 2024 Apr;
15(1):3557.
PMID: 38670944
Genome-wide association studies (GWAS) have identified more than 200 common genetic variants independently associated with colorectal cancer (CRC) risk, but the causal variants and target genes are mostly unknown. We...
7.
Schmit S, Tsai Y, Bonner J, Sanz-Pamplona R, Joshi A, Ugai T, et al.
BMC Genomics
. 2024 Apr;
25(1):409.
PMID: 38664626
Objective: To evaluate the contribution of germline genetics to regulating the briskness and diversity of T cell responses in CRC, we conducted a genome-wide association study to examine the associations...
8.
Tsai Y, Qu C, Bonner J, Sanz-Pamplona R, Lindsey S, Melas M, et al.
Front Immunol
. 2023 Nov;
14:1268117.
PMID: 37942321
Objective: Reduced diversity at Human Leukocyte Antigen (HLA) loci may adversely affect the host's ability to recognize tumor neoantigens and subsequently increase disease burden. We hypothesized that increased heterozygosity at...
9.
Severe Immune-Mediated Colitis Induced by Checkpoint Inhibitors in an Adolescent With Lynch Syndrome
Lee R, Melstrom K, Mannan R, Idos G, Kidambi T
Cureus
. 2023 Sep;
15(8):e43246.
PMID: 37692727
Lynch syndrome is a hereditary colorectal cancer caused by mutations in DNA mismatch repair genes. Immune checkpoint therapies have shown promise in treating Lynch syndrome-associated cancers but can lead to...
10.
Hodan R, Rodgers-Fouche L, Chittenden A, Dominguez-Valentin M, Ferriss J, Gima L, et al.
Fam Cancer
. 2023 Jun;
22(4):437-448.
PMID: 37341816
Transgender and gender diverse (TGD) populations with hereditary cancer syndromes face unique obstacles to identifying and obtaining appropriate cancer surveillance and risk-reducing procedures. There is a lack of care provider...